Stay updated with breaking news from Bleeding Disorder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New research by RCSI University of Medicine and Health Sciences published in Blood journal has revealed that the age at which individuals are tested for von Willebrand disease (VWD), a common bleeding disorder, significantly affects their diagnosis.
Explore the prevalence of hemophilia A in the United States and its profound clinical impact on patients, delving into the challenges and implications of managing this bleeding disorder. Additionally, gain valuable insights into the economic costs associated with the comprehensive care required for individuals with hemophilia A, shedding light on the financial burdens faced by both patients and healthcare systems.
Lisa Schrade, PharmD, and Robert Sidonio Jr, MD, MSc, explore the integral partnership between specialty pharmacists and hematologists in managing patients with hemophilia.
While clinical trials offer controlled data, real-world studies like HEM-POWR bridge gaps, confirming damoctocog alfa pegol’s effectiveness and tolerance, establishing it as a valuable hemophilia A treatment option.
Amid widely differing capacities of available menstrual hygiene products, a menstrual disc-;similar in shape to a diaphragm-;may be best for dealing with heavy monthly blood flow as well as indicating excessive blood loss, suggests research published online in the journal BMJ Sexual & Reproductive Health.